NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Iovance Biotherapeutics Inc (NASDAQ: IOVA)

 
IOVA Technical Analysis
5
As on 8th May 2025 IOVA STOCK Price closed @ 3.17 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 10.06 & Strong Sell for SHORT-TERM with Stoploss of 7.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IOVASTOCK Price

Open 3.18 Change Price %
High 3.31 1 Day 0.04 1.28
Low 3.08 1 Week -0.39 -10.96
Close 3.17 1 Month -0.27 -7.85
Volume 15622144 1 Year -2.32 -42.26
52 Week High 17.47 | 52 Week Low 2.85
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
DGLY 0.06 20.00%
GNLN 0.01 0.00%
NVDA 117.37 0.26%
LMDX 0.02 0.00%
PLUG 0.85 8.97%
AKTS 0.04 0.00%
TSLA 284.82 3.11%
ZKIN 2.52 123.01%
VEEE 7.45 192.16%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
SRAX 0.38 533.33%
ZVZZT 73.39 204.52%
NDRAW 0.03 200.00%
VEEE 7.45 192.16%
GLSPT 33.43 138.62%
CTHR 0.28 133.33%
 
NASDAQ USA Top Losers Stocks
LGHLW 0.00 -100.00%
TBIO 0.01 -91.67%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
NBSTU 2.00 -82.44%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
VOR 0.16 -70.37%
VOR 0.16 -70.37%
AXDX 0.14 -70.21%
 
 
IOVA
Daily Charts
IOVA
Intraday Charts
Whats New @
Bazaartrend
IOVA
Free Analysis
 
IOVA Important Levels Intraday
RESISTANCE3.61
RESISTANCE3.47
RESISTANCE3.38
RESISTANCE3.30
SUPPORT3.04
SUPPORT2.96
SUPPORT2.87
SUPPORT2.73
 
IOVA Forecast May 2025
4th UP Forecast11.94
3rd UP Forecast9.13
2nd UP Forecast7.39
1st UP Forecast5.65
1st DOWN Forecast0.69
2nd DOWN Forecast-1.05
3rd DOWN Forecast-2.79
4th DOWN Forecast-5.6
 
IOVA Weekly Forecast
4th UP Forecast5.64
3rd UP Forecast4.85
2nd UP Forecast4.36
1st UP Forecast3.87
1st DOWN Forecast2.47
2nd DOWN Forecast1.98
3rd DOWN Forecast1.49
4th DOWN Forecast0.70
 
IOVA Forecast2025
4th UP Forecast33.29
3rd UP Forecast23.63
2nd UP Forecast17.66
1st UP Forecast11.69
1st DOWN Forecast-5.35
2nd DOWN Forecast-11.32
3rd DOWN Forecast-17.29
4th DOWN Forecast-26.95
 
 
IOVA Other Details
Segment EQ
Market Capital 3873086976.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IOVA Address
IOVA
 
IOVA Latest News
 
Your Comments and Response on Iovance Biotherapeutics Inc
 
IOVA Business Profile
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. Address: 999 Skyway Road, San Carlos, CA, United States, 94070
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service